Prize Funding

Across the Challenge Objectives (Innovation, Integration, Implementation), we seek to identify a transformative solution to win a grand prize award of up to £1 million. Additional prize funding will be allocated to further winning submissions. 

We expect that one or more collaborators from our Challenge network of members will offer mentorship to the winning solutions and we anticipate that awardees will be connected with post-award innovation and monitoring support. The member list of the inaugural Challenge in 2020 can be viewed here.

The exact amount of the award for each winner will depend on the solution’s needs for development, deployment and scaling over the next three years. Following the application stage, shortlisted Challenge finalists will be asked to provide more detailed plans to inform award funding decisions. 

Prize funding awards will be contractually binding between applicants and the Trinity Challenge and must be used to develop the solutions and further the aims of The Trinity Challenge on Antimicrobial Resistance.

Other awards may be made at the discretion of the Judges (e.g., honorable mentions for solutions outstandingly meeting some criteria).

Prize Eligibility

The Trinity Challenge welcomes submissions in English, from anyone, anywhere in the world, including previous applicants. Applicants from LMICs are especially welcome. In addition to offering prize funding, the Trinity Challenge will aim to support winning solutions by enabling collaborations with its Challenge network of members.

Within their submission, applicants must outline how their solution provides a public benefit that would be globally accessible under fair, reasonable and non-discriminatory terms.

The Trinity Challenge on Antimicrobial Resistance is focused exclusively on finding solutions in LMICs. 

While submissions are welcomed from organizations based in high-income countries (HICs), in keeping with the focus of this Challenge and the vision of The Trinity Challenge, applicants from HICs must demonstrate bona fide partnerships with LMIC researchers or organizations as part of the challenge team. This must also be reflected in the flow of funds in the budget proposal and justification. Furthermore, data must be relevant to, or collected from, LMICs, and not HICs.

Government agencies or their foundations cannot apply to the Challenge. Individuals from within these entities, but not the entity itself, may apply as a part of the solution team.

While submissions are welcome from anyone, the following eligibility criteria must be met in order to receive prize funding.

Prize funding is available to any of the following entities:

• Teams or institutions, provided that they will create or appoint a legally registered organization in the home jurisdiction with a bank account to receive prize funding 

• Organizations, in any form, that are legally registered in their home jurisdiction with a bank account registered to that organization

• A consortium of the above, provided that a lead organization and lead individual is identified

• The Trinity Challenge may require that a prize winner appoints a fiscal sponsor to receive and administer any award funds on their behalf

Prize funding will not be awarded to any of the following:

• Individuals or those under 18 years of age

• Applicants that focus on interventions in HICs 

• Any donor that has made a financial contribution to The Trinity Challenge prize fund

• Government agencies or their foundations

• Any applicant that fails the Trinity Challenge due diligence checks 

• Any applicant that does not agree to the Trinity Challenge Award Agreement

• A submission from an organization operating in a sanctioned country (see Terms of Service)

• For-profit companies that fulfill (or are controlled by a for-profit group that fulfills) any two of the following conditions:

  • Annual revenue/turnover in excess of £50 million per year

  • Balance sheet net assets in excess of £20 million

  • Average monthly FTE employees in excess of 250

The Trinity Challenge on Antimicrobial Resistance supports the FAIR principles, CARE principles, and the principle of open-access data and encourages applications from solutions teams that reflect a wide range of perspectives and life experiences.